UK markets closed

Molecular Partners AG (0QXX.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
5.99+0.06 (+1.00%)
At close: 05:32PM GMT
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3N/A
S&P500 52-week change 3-7.75%
52-week high 35.99
52-week low 35.99
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 521.18M
Implied shares outstanding 6N/A
Float 818.68M
% held by insiders 114.14%
% held by institutions 144.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 62.20%
Operating margin (ttm)61.35%

Management effectiveness

Return on assets (ttm)31.63%
Return on equity (ttm)62.46%

Income statement

Revenue (ttm)188.71M
Revenue per share (ttm)5.82
Quarterly revenue growth (yoy)-33.10%
Gross profit (ttm)-45.96M
EBITDA 116.6M
Net income avi to common (ttm)117.37M
Diluted EPS (ttm)3.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)267.13M
Total cash per share (mrq)8.22
Total debt (mrq)5.15M
Total debt/equity (mrq)2.05
Current ratio (mrq)14.37
Book value per share (mrq)7.73

Cash flow statement

Operating cash flow (ttm)113.5M
Levered free cash flow (ttm)64.54M